BRUSELAS

BRUSELAS performs 3D ligand-based virtual screening to compare molecular shapes and pharmacophores across large chemical libraries for drug discovery and pharmacological research.

Key Features:

• High-throughput 3D screening: Performs rapid, unrestricted searches across large off-the-shelf molecular libraries using high-performance computing (HPC).
• Shape and pharmacophore integration: Integrates a diverse array of shape and pharmacophore similarity algorithms to evaluate structural and functional complementarity.
• Consensus scoring: Employs consensus scoring functions to mitigate bias from individual algorithms and enhance reliability of results.
• Scalability for large databases: Handles extensive molecular databases to support large-scale virtual screening campaigns.

Scientific Applications:

• Benchmarking and comparative assessment: Evaluated against established servers such as USR-VS, SwissSimilarity, and ChemMapper.
• Drug discovery screening: Applied to identify potential antidiabetic drugs and support early-stage pharmacological screening of large molecular libraries.

Methodology:

Combines multiple shape and pharmacophore similarity algorithms with consensus scoring and leverages high-performance computing to execute balanced 3D ligand-based virtual screening across large molecular libraries.